Description: Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Home Page: neurostar.com
3222 Phoenixville Pike
Malvern,
PA
19355
United States
Phone:
610 640 4202
Officers
| Name | Title |
|---|---|
| Mr. Keith J. Sullivan | President, CEO & Director |
| Mr. Stephen J. Furlong M.S. | Executive VP, CFO & Treasurer |
| Mr. Rusty Page | Senior VP of Operations & Quality |
| Ms. Lisa Metzner-Rosas | Senior VP & Chief Marketing Officer |
| Ms. Sara Grubbs | Senior VP & Chief Revenue Officer |
| Mr. Rick Grubbs | Senior Vice President of National Accounts |
| Mr. Cory S. Anderson | Senior Vice President of R&D and Clinical |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.0065 |
| Price-to-Sales TTM: | 0.4927 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 203 |